ELI LILLY (I1F-MC-RHBW)

By June 19, 2019 Closed

A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis

Join the discussion 6 Comments

Leave a Reply